Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Destiny Pharma, Invinity Energy Systems

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares. Focusing on MRSA, other post-operative infections and those chronically ill after taking antibiotics, the company's products had the potential to generate annual sales of over £2bn.

While still in development, some were being tested in laboratories and two had already achieved "extremely promising" results, the tipster said.

Indeed, millions of patients recovering from illnesses and surgery might be helped, with lives even saved and healthcare costs reduced.

Midas also highlighted the track record of Destiny's chief executive officer, Chris Tovey, who played a central role in GW Pharma's transformation from a biotech outfit into a commercial business.

In the process, GW floated on the US Nasdaq at $8.90 a share in 2013 and was bought for $220 eight years later.

Destiny chairman Sir Nigel Rudd was also a safe pair of hands and was "well-known for making money for shareholders".

"Destiny Pharma's drugs are designed to curb the use of antibiotics, help the sick to recover faster and cut healthcare costs.

"The shares have had their ups and downs - and biotech firms are never without risk - but Rudd and Tovey's arrival on the board should inspire confidence. At 50p, Destiny is a long-term buy."

The Sunday Times's Lucy Tobin tipped shares of Invinity Energy Systems to readers, in anticipation of the roll-out yof Mistral, the company's new vanadium flow batteries.

Although they will likely cost twice as much as their lithium equivalents, they will probably last more than four times longer.

Developed together with Siemes, the could also tolerate a large spectrum of temperatures, charge and discharge quite quickly and did not ignite.

Tobin nevertheless pointed out two potential red flags, the fact that Invinity was still turning a loss and its capital position.

Invinity itself had already said as much, telling shareholders it would require more capital in 2024, having already raised £16m during the present year.

Analysts meanwhile expected the company to end 2024 with £20m of debt on its books-

However, the company was expected to turn cashflow positive in 2025.

"It's risky, but the firm's tech is already on sale and impressing blue-chip buyers. Buy."

Share this article

Related Sharecast Articles

Sunday newspaper round-up: Middle East, Aston Martin, Defence
(Sharecast News) - Britons must accept that their country was now involved in the Middle East conflict, Tobias Ellwood said. The former defence minister warned that "nobody was in full control" of the growing conflict as more and more countries were sucked in. Ellwood also said that Tehran's strike had taken the conflict into a "new dangerous territory". - Sunday Telegraph
Friday newspaper round-up: Everton, AstraZeneca, Amazon
(Sharecast News) - Everton has paid about £30m in interest charges to an opaque lender associated with a tax exile, corporate records suggest. The charges appear to have reached about £438,000 a week, according to the troubled Premier League club's most recent set of accounts, a figure more than three times the reported wages of the Everton and England goalkeeper Jordan Pickford. - Guardian
Thursday newspaper round-up: Border controls, McKinsey, KPMG
(Sharecast News) - New post-Brexit UK border controls coming into force later this month will cost British businesses £2bn and fuel higher inflation, according to a report warning that UK-EU trade will be damaged as a result. With less than a month before the introduction of new checks on animal and plant products from 30 April, the insurer Allianz Trade said the controls agreed under Boris Johnson's Brexit deal could add 10% to import costs over the first year. - Guardian
Wednesday newspaper round-up: Shoplifting, EnQuest, Klarna
(Sharecast News) - The government is investing more than £55m in expanding facial recognition systems - including vans that will scan crowded high streets - as part of a renewed crackdown on shoplifting. The scheme was announced alongside plans for tougher punishments for serial or abusive shoplifters in England and Wales, including being forced to wear a tag to ensure they do not revisit the scene of their crime, under a new standalone criminal offence of assaulting a retail worker. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.